National Institute of General Medical Sciences; Notice of Closed Meeting, 31762-31763 [2024-08827]
Download as PDF
<![CDATA[
31762
Federal Register / Vol. 89, No. 81 / Thursday, April 25, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://videocast.
nih.gov/watch=54528).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: May 29, 2024.
Open: May 29, 2024, 9:30 a.m. to 2:45 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institutes of Health,
Building 31, 31 Center Street, 6C Room A&B,
Bethesda, MD 20892 (Hybrid Meeting).
Closed: May 29, 2024, 3:30 p.m. to 4:00
p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Street, Bethesda, MD
20892.
Contact Person: Darren D. Sledjeski, Ph.D.,
Director, Division of Extramural Activities
(DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Bethesda, MD 20892, (301)
451–7766, darren.sledjeski@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
VerDate Sep<11>2014
18:54 Apr 24, 2024
Jkt 262001
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.niams.nih.gov/about/working-groups/
advisory-council, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: April 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–08825 Filed 4–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Training and Workforce Development
Study Section—A.
Date: June 6–7, 2024.
Time: 9:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Latarsha J. Carithers,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
of Health, 45 Center Drive, Room 3AN12C,
Bethesda, Maryland 20892, 301–594–4859,
latarsha.carithers@nih.gov.
Marcienne Michele Wright, Scientific
Review Officer, Office of Scientific Review,
National Institutes of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Bethesda, Maryland 20892,
301–827–7635, marci.wright@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Predoctoral T32 SEP.
Date: June 6–7, 2024.
Time: 9:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Marcienne Michele
Wright, Scientific Review Officer, Office of
Scientific Review, National Institutes of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Bethesda,
Maryland 20892, 301–827–7635,
marci.wright@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Training and Workforce Development
Study Section—B.
Date: June 27–28, 2024.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Latarsha J. Carithers,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12C,
Bethesda, Maryland 20892, 301–594–4859,
latarsha.carithers@nih.gov.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel, Centers of Biomedical Research
Excellence (COBRE), Phase I.
Date: July 9–10, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Lisa A. Dunbar, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Room 3AN18D,
Bethesda, Maryland 20892, 301–594–2849,
dunbarl@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Centers of Biomedical
Research, Excellence—COBRE (P20)
Applications.
Date: July 16–17, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
E:\FR\FM\25APN1.SGM
25APN1
Federal Register / Vol. 89, No. 81 / Thursday, April 25, 2024 / Notices
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Manas Chattopadhyay,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12N,
Bethesda, Maryland 20892, 301–827–5320,
manasc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: April 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–08827 Filed 4–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Chimeric
Antigen Receptor Approaches to AD/ADRD
R61 Review Meeting.
Date: July 9, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ivan Tadeu Rebustini,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
7201 Wisconsin Avenue, Gateway Bldg.
Room 100, Bethesda, MD 20814, (301) 555–
1212, ivan.rebustini@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
VerDate Sep<11>2014
18:54 Apr 24, 2024
Jkt 262001
Dated: April 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–08826 Filed 4–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Mental Health Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will also be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: May 30–31, 2024.
Open: May 30, 2024, 1:00 p.m. to 4:45 p.m.
Agenda: Presentation of the NIMH
Director’s Report and discussion of NIMH
programs.
Place: National Institute of Mental Health,
Neuroscience Center, 6001 Executive
Boulevard, Rooms 1145 & 1155, Rockville,
MD 20852 (In Person Meeting).
Closed: May 31, 2024, 9:00 a.m. to 1:00
p.m.
Agenda: To review and evaluate grant
applications and/or contract proposals.
Place: National Institute of Mental Health,
Neuroscience Center, 6001 Executive
Boulevard, Rooms 1145 & 1155, Rockville,
MD 20852 (In-Person Meeting).
Contact Person: Tracy L. Waldeck, Ph.D.,
Director Division of Extramural Activities,
National Institute of Mental Health, NIH,
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
31763
DHHS, Neuroscience Center, 6001 Executive
Boulevard, Bethesda, MD 20892, (301) 480–
6833, tracy.waldeck@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
www.nimh.nih.gov/about/advisory-boardsand-groups/namhc/index.shtml., where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: April 19, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–08831 Filed 4–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[BLM_NM_FRN_MO#4500179000; NM–
106239540]
Public Land Order No. 7940; Placitas
Area Withdrawal, New Mexico
Bureau of Land Management,
Interior.
ACTION: Public land order.
AGENCY:
This Public Land Order (PLO)
withdraws 4,212.98 acres of public
lands from location and entry under the
United States mining laws, from leasing
under the mineral leasing laws, and
SUMMARY:
E:\FR\FM\25APN1.SGM
25APN1
]]>Agencies
[Federal Register Volume 89, Number 81 (Thursday, April 25, 2024)]
[Notices]
[Pages 31762-31763]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-08827]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Initial Review Group; Training and Workforce Development
Study Section--A.
Date: June 6-7, 2024.
Time: 9:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Latarsha J. Carithers, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12C, Bethesda, Maryland 20892, 301-594-4859,
[email protected].
Marcienne Michele Wright, Scientific Review Officer, Office of
Scientific Review, National Institutes of General Medical Sciences,
National Institutes of Health, 45 Center Drive, Bethesda, Maryland
20892, 301-827-7635, [email protected].
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; NIGMS Predoctoral T32 SEP.
Date: June 6-7, 2024.
Time: 9:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Marcienne Michele Wright, Scientific Review
Officer, Office of Scientific Review, National Institutes of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Bethesda, Maryland 20892, 301-827-7635, [email protected].
Name of Committee: National Institute of General Medical
Sciences Initial Review Group; Training and Workforce Development
Study Section--B.
Date: June 27-28, 2024.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Latarsha J. Carithers, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12C, Bethesda, Maryland 20892, 301-594-4859,
[email protected].
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel, Centers of Biomedical Research
Excellence (COBRE), Phase I.
Date: July 9-10, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Lisa A. Dunbar, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
MSC 6200, Room 3AN18D, Bethesda, Maryland 20892, 301-594-2849,
[email protected].
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of Centers of Biomedical
Research, Excellence--COBRE (P20) Applications.
Date: July 16-17, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical
[[Page 31763]]
Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland
20892 (Virtual Meeting).
Contact Person: Manas Chattopadhyay, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12N, Bethesda, Maryland 20892, 301-827-5320,
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.859,
Biomedical Research and Research Training, National Institutes of
Health, HHS)
Dated: April 19, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-08827 Filed 4-24-24; 8:45 am]
BILLING CODE 4140-01-P
